公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2020 | Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis | SHANG-YI HUANG ; Yoon S.-S.; Shimizu K.; Chng W.J.; Chang C.-S.; Wong R.S.-M.; Gao S.; Wang Y.; Gordon S.W.; Glennane A.; Min C.-K. | Advances in Therapy | 11 | 8 |